To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
Sustainability-related
disclosures
Contact
.
News
Vesalius News
01/24/2023
Memo Therapeutics: Positive Phase I Data
read more
12/14/2022
CatalYm: Visugromab Development
read more
11/22/2022
CatalYm: EUR 50 Million Financing
read more
.
xxnoxx_zaehler